Symbols / ANIX $3.14 +9.03% Anixa Biosciences, Inc.

Healthcare • Biotechnology • United States • NCM
ANIX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Fundamentals
Scroll to Statements
Market Cap 105.28M Enterprise Value 81.32M Income -10.31M Sales — Book/sh 0.45 Cash/sh 0.42
Dividend Yield — Payout 0.00% Employees 4 IPO — P/E — Forward P/E -8.49
PEG -0.11 P/S — P/B 6.96 P/C — EV/EBITDA — EV/Sales —
Quick Ratio 11.49 Current Ratio 12.18 Debt/Eq 1.39 LT Debt/Eq — EPS (ttm) -0.32 EPS next Y -0.37
EPS Growth — Revenue Growth — Earnings 2026-05-28 ROA -40.39% ROE -68.06% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 33.53M Shs Float 31.72M Short Float 3.62%
Short Ratio 11.72 Short Interest — 52W High 5.46 52W Low 2.44 Beta 0.58 Avg Volume 130.59K
Volume 239.39K Target Price $10.75 Recom Strong_buy Prev Close $2.88 Price $3.14 Change 9.03%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.75
Mean price target
2. Current target
$3.14
Latest analyst target
3. DCF / Fair value
$-1.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.14
Low
$9.00
High
$14.00
Mean
$10.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main D. Boral Capital Buy → Buy $10
2026-03-31 main D. Boral Capital Buy → Buy $10
2026-02-04 main D. Boral Capital Buy → Buy $10
2025-12-12 main D. Boral Capital Buy → Buy $10
2025-10-07 main D. Boral Capital Buy → Buy $10
2025-09-22 main D. Boral Capital Buy → Buy $10
2025-09-11 reit HC Wainwright & Co. Buy → Buy $7
2025-09-09 main D. Boral Capital Buy → Buy $10
2025-08-19 main D. Boral Capital Buy → Buy $10
2025-08-05 main D. Boral Capital Buy → Buy $10
2025-06-10 main D. Boral Capital Buy → Buy $10
2025-05-29 main D. Boral Capital Buy → Buy $10
2025-04-10 main D. Boral Capital Buy → Buy $10
2025-03-26 main D. Boral Capital Buy → Buy $10
2025-03-25 reit HC Wainwright & Co. Buy → Buy $7
2025-03-21 init Maxim Group — → Buy $10
2025-02-18 reit HC Wainwright & Co. Buy → Buy $7
2025-01-22 main D. Boral Capital Buy → Buy $10
2025-01-14 main D. Boral Capital Buy → Buy $10
2024-11-19 main D. Boral Capital Buy → Buy $10
News
RSS: Latest ANIX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-28 BASKIES ARNOLD M Director — 10,000 $3.04 $30,400
2025-12-15 TITTERTON LEWIS H JR Director — 16,000 $2.92 $46,720
2025-10-30 KUMAR AMIT Chief Executive Officer — 200,000 $2.92 $584,000
2025-07-31 TITTERTON LEWIS H JR Director — 10,000 $3.08 $30,800
2025-07-30 KUMAR AMIT Chief Executive Officer — 5,000 $3.16 $15,800
2025-07-18 BASKIES ARNOLD M Director — 5,000 $3.39 $16,950
2025-07-11 KUMAR AMIT Chief Executive Officer — 5,000 $3.15 $15,750
2025-07-11 TITTERTON LEWIS H JR Director — 10,000 $3.14 $31,400
2025-06-04 KUMAR AMIT Chief Executive Officer — 10,000 $2.85 $28,500
2025-01-28 BASKIES ARNOLD M Director — 5,000 $2.82 $14,100
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Revenue
0.00
0.00
-100.00%
0.21
0.00
Operating Revenue
0.00
0.00
-100.00%
0.21
0.00
Cost Of Revenue
—
0.00
-100.00%
0.16
0.00
Reconciled Cost Of Revenue
—
0.00
-100.00%
0.16
0.00
Gross Profit
—
0.00
-100.00%
0.05
0.00
Operating Expense
11.70
-15.40%
13.83
+25.05%
11.06
-20.29%
13.88
Research And Development
5.07
-20.72%
6.40
+34.12%
4.77
-28.85%
6.70
Selling General And Administration
6.63
-10.83%
7.43
+18.18%
6.29
-12.28%
7.17
General And Administrative Expense
6.63
-10.83%
7.43
+18.18%
6.29
-12.28%
7.17
Other Gand A
6.63
-10.83%
7.43
+18.18%
6.29
-12.28%
7.17
Total Expenses
11.70
-15.40%
13.83
+23.26%
11.22
-19.13%
13.88
Operating Income
-11.70
+15.40%
-13.83
-25.61%
-11.01
+20.64%
-13.88
Total Operating Income As Reported
-11.70
+15.40%
-13.83
-25.61%
-11.01
+20.64%
-13.88
EBITDA
-11.66
+15.43%
-13.79
-25.80%
-10.96
+20.73%
-13.83
Normalized EBITDA
-11.66
+15.43%
-13.79
-25.80%
-10.96
+20.73%
-13.83
Reconciled Depreciation
0.04
-2.70%
0.04
-19.57%
0.05
+9.52%
0.04
EBIT
-11.70
+15.40%
-13.83
-25.61%
-11.01
+20.64%
-13.88
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Net Income
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Pretax Income
-11.03
+13.15%
-12.70
-27.88%
-9.93
+27.89%
-13.77
Net Non Operating Interest Income Expense
0.67
-40.60%
1.13
+4.81%
1.08
+939.42%
0.10
Net Interest Income
0.67
-40.60%
1.13
+4.81%
1.08
+939.42%
0.10
Interest Income Non Operating
0.67
-40.60%
1.13
+4.81%
1.08
+939.42%
0.10
Interest Income
0.67
-40.60%
1.13
+4.81%
1.08
+939.42%
0.10
Other Income Expense
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-11.03
+13.15%
-12.70
-27.88%
-9.93
+27.89%
-13.77
Net Income From Continuing Operation Net Minority Interest
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Net Income From Continuing And Discontinued Operation
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Net Income Continuous Operations
-11.03
+13.15%
-12.70
-27.88%
-9.93
+27.89%
-13.77
Minority Interests
0.10
-29.86%
0.14
+21.01%
0.12
-32.39%
0.18
Normalized Income
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Net Income Common Stockholders
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Diluted EPS
-0.34
+12.82%
-0.39
-21.88%
-0.32
+28.89%
-0.45
Basic EPS
-0.34
+12.82%
-0.39
-21.88%
-0.32
+28.89%
-0.45
Basic Average Shares
32.45
+1.74%
31.90
+2.96%
30.98
+2.00%
30.37
Diluted Average Shares
32.45
+1.74%
31.90
+2.96%
30.98
+2.00%
30.37
Diluted NI Availto Com Stockholders
-10.93
+12.96%
-12.55
-27.96%
-9.81
+27.83%
-13.60
Gain On Sale Of PPE
—
—
—
0.00
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Assets
16.08
-25.52%
21.59
-15.40%
25.52
-16.08%
30.41
Current Assets
15.89
-25.63%
21.36
-15.75%
25.36
-16.04%
30.20
Cash Cash Equivalents And Short Term Investments
15.17
-23.84%
19.92
-16.44%
23.84
-19.68%
29.69
Cash And Cash Equivalents
1.24
-2.12%
1.27
+38.91%
0.92
-92.60%
12.36
Other Short Term Investments
13.93
-25.32%
18.65
-18.65%
22.93
+32.33%
17.33
Receivables
0.00
-100.00%
0.17
-35.93%
0.27
+486.96%
0.05
Accounts Receivable
0.00
-100.00%
0.17
-35.93%
0.27
+486.96%
0.05
Prepaid Assets
—
—
—
0.51
Other Current Assets
0.71
-43.64%
1.26
+1.85%
1.24
+165.95%
0.47
Total Non Current Assets
0.19
-15.72%
0.23
+37.95%
0.17
-21.70%
0.21
Net PPE
0.19
-15.72%
0.23
+37.95%
0.17
-21.70%
0.21
Gross PPE
0.19
-15.72%
0.23
+37.95%
0.17
-21.70%
0.21
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.19
-15.72%
0.23
+37.95%
0.17
-21.70%
0.21
Leases
0.19
-15.72%
0.23
+37.95%
0.17
-21.70%
0.21
Total Liabilities Net Minority Interest
2.13
-21.20%
2.70
+25.66%
2.15
-2.76%
2.21
Current Liabilities
1.97
-21.32%
2.50
+23.27%
2.03
-0.44%
2.04
Payables And Accrued Expenses
1.93
-22.06%
2.47
+25.05%
1.98
-0.75%
1.99
Payables
0.17
-68.57%
0.53
+154.85%
0.21
-22.26%
0.27
Accounts Payable
0.17
-68.57%
0.53
+154.85%
0.21
-22.26%
0.27
Current Accrued Expenses
1.76
-9.51%
1.95
+9.94%
1.77
+2.55%
1.73
Current Debt And Capital Lease Obligation
0.04
+41.38%
0.03
-44.23%
0.05
+13.04%
0.05
Current Capital Lease Obligation
0.04
+41.38%
0.03
-44.23%
0.05
+13.04%
0.05
Total Non Current Liabilities Net Minority Interest
0.16
-19.70%
0.20
+65.04%
0.12
-29.71%
0.17
Long Term Debt And Capital Lease Obligation
0.16
-19.70%
0.20
+65.04%
0.12
-29.71%
0.17
Long Term Capital Lease Obligation
0.16
-19.70%
0.20
+65.04%
0.12
-29.71%
0.17
Stockholders Equity
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Common Stock Equity
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Capital Stock
0.33
+2.48%
0.32
+3.54%
0.31
+0.65%
0.31
Common Stock
0.33
+2.48%
0.32
+3.54%
0.31
+0.65%
0.31
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
33.01
+2.54%
32.20
+3.38%
31.15
+0.75%
30.91
Ordinary Shares Number
33.01
+2.54%
32.20
+3.38%
31.15
+0.75%
30.91
Additional Paid In Capital
266.51
+2.33%
260.43
+3.26%
252.22
+2.06%
247.12
Retained Earnings
-251.68
-4.54%
-240.75
-5.50%
-228.20
-4.49%
-218.38
Treasury Stock
0.00
-100.00%
0.01
0.00
—
Minority Interest
-1.21
-9.10%
-1.11
-14.91%
-0.97
-14.05%
-0.85
Total Equity Gross Minority Interest
13.95
-26.14%
18.89
-19.18%
23.37
-17.12%
28.20
Total Capitalization
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Working Capital
13.92
-26.20%
18.86
-19.14%
23.33
-17.17%
28.16
Invested Capital
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Total Debt
0.20
-12.07%
0.23
+32.57%
0.17
-20.81%
0.22
Capital Lease Obligations
0.20
-12.07%
0.23
+32.57%
0.17
-20.81%
0.22
Net Tangible Assets
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Tangible Book Value
15.16
-24.19%
20.00
-17.83%
24.34
-16.22%
29.05
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Operating Cash Flow
-7.17
+2.21%
-7.33
-18.13%
-6.21
+4.36%
-6.49
Cash Flow From Continuing Operating Activities
-7.17
+2.21%
-7.33
-18.13%
-6.21
+4.36%
-6.49
Net Income From Continuing Operations
-11.03
+13.15%
-12.70
-27.88%
-9.93
+27.89%
-13.77
Depreciation Amortization Depletion
0.04
-2.70%
0.04
-19.57%
0.05
+9.52%
0.04
Depreciation
0.04
-2.70%
0.04
-19.57%
0.05
+9.52%
0.04
Depreciation And Amortization
0.04
-2.70%
0.04
-19.57%
0.05
+9.52%
0.04
Other Non Cash Items
0.13
-66.05%
0.38
+21.41%
0.31
-58.38%
0.75
Stock Based Compensation
3.68
-16.72%
4.42
-0.05%
4.42
-26.30%
6.00
Operating Gains Losses
—
—
—
—
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
0.15
-71.10%
0.53
+149.62%
-1.06
-318.56%
0.48
Change In Receivables
0.17
+78.35%
0.10
+143.30%
-0.22
-672.41%
-0.03
Change In Prepaid Assets
0.55
+2500.00%
-0.02
+97.03%
-0.78
-272.60%
-0.21
Change In Payables And Accrued Expense
-0.55
-210.10%
0.49
+3400.00%
-0.01
-101.97%
0.76
Change In Accrued Expense
-0.18
-205.11%
0.18
+300.00%
0.04
-93.03%
0.63
Change In Payable
-0.36
-212.85%
0.32
+640.68%
-0.06
-145.74%
0.13
Change In Account Payable
-0.36
-212.85%
0.32
+640.68%
-0.06
-145.74%
0.13
Change In Other Working Capital
—
—
—
—
Change In Other Current Liabilities
-0.03
+34.88%
-0.04
+6.52%
-0.05
-21.05%
-0.04
Investing Cash Flow
4.87
+13.80%
4.28
+176.33%
-5.60
+47.78%
-10.73
Cash Flow From Continuing Investing Activities
4.87
+13.80%
4.28
+176.33%
-5.60
+47.78%
-10.73
Net PPE Purchase And Sale
—
—
—
0.00
Purchase Of PPE
—
—
—
—
Sale Of PPE
—
—
—
0.00
Net Investment Purchase And Sale
4.87
+13.80%
4.28
+176.33%
-5.60
+47.78%
-10.73
Purchase Of Investment
-44.36
+30.44%
-63.77
-43.59%
-44.41
-97.51%
-22.49
Sale Of Investment
49.23
-27.66%
68.05
+75.34%
38.81
+230.06%
11.76
Net Business Purchase And Sale
—
—
—
0.00
Gain Loss On Sale Of Business
—
—
—
—
Financing Cash Flow
2.28
-33.24%
3.42
+833.06%
0.37
-19.03%
0.45
Cash Flow From Continuing Financing Activities
2.28
-33.24%
3.42
+833.06%
0.37
-19.03%
0.45
Net Common Stock Issuance
2.38
-19.36%
2.95
0.00
0.00
Common Stock Payments
0.00
+100.00%
-0.01
0.00
—
Repurchase Of Capital Stock
0.00
+100.00%
-0.01
0.00
—
Proceeds From Stock Option Exercised
-0.10
-121.03%
0.47
+27.32%
0.37
-19.03%
0.45
Changes In Cash
-0.03
-107.58%
0.36
+103.11%
-11.45
+31.74%
-16.77
Beginning Cash Position
1.27
+38.91%
0.92
-92.60%
12.36
-57.57%
29.13
End Cash Position
1.24
-2.12%
1.27
+38.91%
0.92
-92.60%
12.36
Free Cash Flow
-7.17
+2.21%
-7.33
-18.13%
-6.21
+4.36%
-6.49
Amortization Of Securities
-0.14
0.00
—
—
Common Stock Issuance
2.38
-19.53%
2.96
0.00
0.00
Issuance Of Capital Stock
2.38
-19.53%
2.96
0.00
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category